Paper3479985
Bone-derived and recombinant transforming growth factor beta's are potent inhibitors of tumor cell growth.
Ranchalis JE and 6 others. Biochem Biophys Res Commun, 1987. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Bone-derived and recombinant transforming growth factor beta's are potent inhibitors of tumor cell growth. Papers, record 3479985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3479985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bone-derived and recombinant transforming growth factor beta's are potent inhibitors of tumor cell growth.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone and Bones | Major topic |
| Growth Substances | Major topic |
| Peptides | Major topic |
| Recombinant Proteins | Major topic |
| Animals | |
| Cell Line | |
| Cell Survival | |
| Drug Screening Assays, Antitumor | |
| Humans | |
| Transforming Growth Factors |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9673234 | Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs. | Infect Immun | 1998 | https://conductscience.org/library/papers/9673234 | PubMed |
| 9488418 | Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. | Infect Immun | 1998 | https://conductscience.org/library/papers/9488418 | PubMed |
| 7682701 | Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7682701 | PubMed |
| 7520475 | Transforming growth factor beta 1 is an inducer of erythroid differentiation. | J Exp Med | 1994 | https://conductscience.org/library/papers/7520475 | PubMed |
| 1908509 | Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). | J Exp Med | 1991 | https://conductscience.org/library/papers/1908509 | PubMed |
| 1846264 | Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. | Am J Pathol | 1991 | https://conductscience.org/library/papers/1846264 | PubMed |
| 1718163 | Serum response heterogeneity among nonsmall cell lung cancer cell lines. | Am J Pathol | 1991 | https://conductscience.org/library/papers/1718163 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3479985
GET https://conductscience.org/api/papers/v1/3479985/authors